These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37149444)

  • 1. Bm Delta-pgm, a vaccine for the control of Brucella melitensis with cross-species protective properties.
    Czibener C; Rey Serantes DA; Romani AM; Bruno L; Pasquevich KA; Cassataro J; Comerci DJ; Ugalde JE
    Vaccine; 2023 May; 41(23):3534-3543. PubMed ID: 37149444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta-pgm, a new live-attenuated vaccine against Brucella suis.
    Czibener C; Del Giudice MG; Spera JM; Fulgenzi FR; Ugalde JE
    Vaccine; 2016 Mar; 34(13):1524-1530. PubMed ID: 26899373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice.
    Zhang Y; Li T; Zhang J; Li Z; Zhang Y; Wang Z; Feng H; Wang Y; Chen C; Zhang H
    World J Microbiol Biotechnol; 2016 Apr; 32(4):58. PubMed ID: 26925620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
    PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model.
    Uslu A; Erganis O
    Mol Immunol; 2021 May; 133():44-52. PubMed ID: 33631554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine Candidate Brucella melitensis 16M
    Hensel ME; Garcia-Gonzalez DG; Chaki SP; Hartwig A; Gordy PW; Bowen R; Ficht TA; Arenas-Gamboa AM
    mSphere; 2020 May; 5(3):. PubMed ID: 32404509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.
    Tabynov K; Yespembetov B; Matikhan N; Ryskeldinova S; Zinina N; Kydyrbayev Z; Assanzhanova N; Tabynov K; Renukaradhya GJ; Mukhitdinova G; Sansyzbay A
    Vet Microbiol; 2016 Dec; 197():15-20. PubMed ID: 27938677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of brucellosis in Kuwait by vaccination of cattle, sheep and goats with Brucella abortus strain 19 or Brucella melitensis strain Rev. 1.
    al-Khalaf SA; Mohamad BT; Nicoletti P
    Trop Anim Health Prod; 1992 Feb; 24(1):45-9. PubMed ID: 1306918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections.
    Zhu L; Feng Y; Zhang G; Jiang H; Zhang Z; Wang N; Ding J; Suo X
    Vaccine; 2016 Jan; 34(3):395-400. PubMed ID: 26626213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination control programs for multiple livestock host species: an age-stratified, seasonal transmission model for brucellosis control in endemic settings.
    Beauvais W; Musallam I; Guitian J
    Parasit Vectors; 2016 Jan; 9():55. PubMed ID: 26825313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.
    el Idrissi AH; Benkirane A; el Maadoudi M; Bouslikhane M; Berrada J; Zerouali A
    Rev Sci Tech; 2001 Dec; 20(3):741-7. PubMed ID: 11732416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A repA-based ELISA for discriminating cattle vaccinated with Brucella suis 2 from those naturally infected with Brucella abortus and Brucella melitensis.
    Wang JY; Wu N; Liu WH; Ren JJ; Tang P; Qiu YH; Wang CY; Chang CD; Liu HJ
    Mol Cell Probes; 2014; 28(5-6):251-4. PubMed ID: 24941369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting roles for IgM and B-cell MHCII expression in
    Abushahba MFN; Dadelahi AS; Ponzilacqua-Silva B; Moley CR; Skyberg JA
    mSphere; 2024 Mar; 9(3):e0075023. PubMed ID: 38349167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model.
    Dabral N; Burcham GN; Jain-Gupta N; Sriranganathan N; Vemulapalli R
    PLoS One; 2019; 14(3):e0213587. PubMed ID: 30856219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
    Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
    Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and risk factors of brucellosis among domestic animals: an artificial neural network approach.
    ZareBidaki M; Allahyari E; Zeinali T; Asgharzadeh M
    Trop Anim Health Prod; 2022 Jan; 54(1):62. PubMed ID: 35037143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective properties of rifampin-resistant rough mutants of Brucella melitensis.
    Adone R; Ciuchini F; Marianelli C; Tarantino M; Pistoia C; Marcon G; Petrucci P; Francia M; Riccardi G; Pasquali P
    Infect Immun; 2005 Jul; 73(7):4198-204. PubMed ID: 15972510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.